Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for publisher:("NEOMED Integrated Pharmaceutical Medicine"). Showing records 1 – 6 of 6 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Logan, Suzanna J. Optimization of Stem Cell Therapies for Coronary Collateral Growth in Cardiovascular Disease.

Degree: PhD, Integrated Pharmaceutical Medicine, 2014, NEOMED Integrated Pharmaceutical Medicine

 Ischemic heart disease is a leading cause of death around the world. Coronary collateral growth occurs as a natural, adaptive response to myocardial ischemia, and… (more)

Subjects/Keywords: Health; Medicine; Cellular Biology; Arteriogenesis, stem cells, ischemic heart disease, coronary collateral growth, oxidative stress, thiazolidinediones

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Logan, S. J. (2014). Optimization of Stem Cell Therapies for Coronary Collateral Growth in Cardiovascular Disease. (Doctoral Dissertation). NEOMED Integrated Pharmaceutical Medicine. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401096082

Chicago Manual of Style (16th Edition):

Logan, Suzanna J. “Optimization of Stem Cell Therapies for Coronary Collateral Growth in Cardiovascular Disease.” 2014. Doctoral Dissertation, NEOMED Integrated Pharmaceutical Medicine. Accessed July 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401096082.

MLA Handbook (7th Edition):

Logan, Suzanna J. “Optimization of Stem Cell Therapies for Coronary Collateral Growth in Cardiovascular Disease.” 2014. Web. 19 Jul 2019.

Vancouver:

Logan SJ. Optimization of Stem Cell Therapies for Coronary Collateral Growth in Cardiovascular Disease. [Internet] [Doctoral dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2014. [cited 2019 Jul 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401096082.

Council of Science Editors:

Logan SJ. Optimization of Stem Cell Therapies for Coronary Collateral Growth in Cardiovascular Disease. [Doctoral Dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2014. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401096082

2. Smith, Matthew Alan. Differential Loss of Bidirectional Axonal Transport with Structural Persistence Within The Same Optic Projection of the DBA/2J Glaucomatous Mouse.

Degree: MS, Integrated Pharmaceutical Medicine, 2014, NEOMED Integrated Pharmaceutical Medicine

 Glaucoma, the second leading cause of blindness worldwide, involves the degeneration of retinal ganglion cell bodies and their axons resulting in progressive vision loss. Much… (more)

Subjects/Keywords: Neurosciences; Neurobiology; Medicine; glaucoma, axonal transport, neurodegeneration, superior colliculus, retina

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smith, M. A. (2014). Differential Loss of Bidirectional Axonal Transport with Structural Persistence Within The Same Optic Projection of the DBA/2J Glaucomatous Mouse. (Masters Thesis). NEOMED Integrated Pharmaceutical Medicine. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401723180

Chicago Manual of Style (16th Edition):

Smith, Matthew Alan. “Differential Loss of Bidirectional Axonal Transport with Structural Persistence Within The Same Optic Projection of the DBA/2J Glaucomatous Mouse.” 2014. Masters Thesis, NEOMED Integrated Pharmaceutical Medicine. Accessed July 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401723180.

MLA Handbook (7th Edition):

Smith, Matthew Alan. “Differential Loss of Bidirectional Axonal Transport with Structural Persistence Within The Same Optic Projection of the DBA/2J Glaucomatous Mouse.” 2014. Web. 19 Jul 2019.

Vancouver:

Smith MA. Differential Loss of Bidirectional Axonal Transport with Structural Persistence Within The Same Optic Projection of the DBA/2J Glaucomatous Mouse. [Internet] [Masters thesis]. NEOMED Integrated Pharmaceutical Medicine; 2014. [cited 2019 Jul 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401723180.

Council of Science Editors:

Smith MA. Differential Loss of Bidirectional Axonal Transport with Structural Persistence Within The Same Optic Projection of the DBA/2J Glaucomatous Mouse. [Masters Thesis]. NEOMED Integrated Pharmaceutical Medicine; 2014. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1401723180

3. DelloStritto, Daniel Justin. TRPing up the Balance of Oxidative Stress - Transient Receptor Potential Vanilloid 1’s Role in Diabetic Microvascular Disease.

Degree: PhD, Integrated Pharmaceutical Medicine, 2016, NEOMED Integrated Pharmaceutical Medicine

 Diabetes is a growing epidemic worldwide leading to an increase in cardiovascular morbidity and mortality. The maintenance of coronary blood flow (CBF) is crucial to… (more)

Subjects/Keywords: Biology; Physiology; TRPV1, Diabetes, ROS, 4-HNE, Hydrogen Peroxide, Differential Regulation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

DelloStritto, D. J. (2016). TRPing up the Balance of Oxidative Stress - Transient Receptor Potential Vanilloid 1’s Role in Diabetic Microvascular Disease. (Doctoral Dissertation). NEOMED Integrated Pharmaceutical Medicine. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1469567446

Chicago Manual of Style (16th Edition):

DelloStritto, Daniel Justin. “TRPing up the Balance of Oxidative Stress - Transient Receptor Potential Vanilloid 1’s Role in Diabetic Microvascular Disease.” 2016. Doctoral Dissertation, NEOMED Integrated Pharmaceutical Medicine. Accessed July 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1469567446.

MLA Handbook (7th Edition):

DelloStritto, Daniel Justin. “TRPing up the Balance of Oxidative Stress - Transient Receptor Potential Vanilloid 1’s Role in Diabetic Microvascular Disease.” 2016. Web. 19 Jul 2019.

Vancouver:

DelloStritto DJ. TRPing up the Balance of Oxidative Stress - Transient Receptor Potential Vanilloid 1’s Role in Diabetic Microvascular Disease. [Internet] [Doctoral dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2016. [cited 2019 Jul 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1469567446.

Council of Science Editors:

DelloStritto DJ. TRPing up the Balance of Oxidative Stress - Transient Receptor Potential Vanilloid 1’s Role in Diabetic Microvascular Disease. [Doctoral Dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2016. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1469567446

4. Khol, Matthew Philip. The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis.

Degree: MS, Integrated Pharmaceutical Medicine, 2014, NEOMED Integrated Pharmaceutical Medicine

 ABSTRACTIntroduction: Healthy bone constantly remodels, in balance between osteoclast bone resorption and osteoblast bone formation. Osteoclasts differentiate in vitro from osteoclast progenitor cells in the… (more)

Subjects/Keywords: Biology, Cell; Recombinant; Osteoactivin; Murine; Osteoclastogenesis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khol, M. P. (2014). The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis. (Masters Thesis). NEOMED Integrated Pharmaceutical Medicine. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380

Chicago Manual of Style (16th Edition):

Khol, Matthew Philip. “The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis.” 2014. Masters Thesis, NEOMED Integrated Pharmaceutical Medicine. Accessed July 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380.

MLA Handbook (7th Edition):

Khol, Matthew Philip. “The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis.” 2014. Web. 19 Jul 2019.

Vancouver:

Khol MP. The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis. [Internet] [Masters thesis]. NEOMED Integrated Pharmaceutical Medicine; 2014. [cited 2019 Jul 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380.

Council of Science Editors:

Khol MP. The Effects of Recombinant Osteoactivin on Murine Osteoclastogenesis. [Masters Thesis]. NEOMED Integrated Pharmaceutical Medicine; 2014. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1424053380

5. Wehrung, Daniel. Development and Evaluation of Novel Light-Responsive Drug Delivery Systems from Alkoxyphenacyl Polycarbonates.

Degree: PhD, Integrated Pharmaceutical Medicine, 2015, NEOMED Integrated Pharmaceutical Medicine

  Stimuli-responsive delivery systems are capable of site-specific drug delivery through the temporal and spatial control over drug release. To date, the clinical relevance of… (more)

Subjects/Keywords: Pharmaceuticals; Pharmacy Sciences; Biomedical Engineering; Nanoscience; Nanotechnology; Drug delivery; Stimuli-responsive; light-responsive; alkoxyphenacyl-based polycarbonates; photon upconversion; nanotechnology; photoreponsive; polymer chain scission; polycarbonate

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wehrung, D. (2015). Development and Evaluation of Novel Light-Responsive Drug Delivery Systems from Alkoxyphenacyl Polycarbonates. (Doctoral Dissertation). NEOMED Integrated Pharmaceutical Medicine. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1441828458

Chicago Manual of Style (16th Edition):

Wehrung, Daniel. “Development and Evaluation of Novel Light-Responsive Drug Delivery Systems from Alkoxyphenacyl Polycarbonates.” 2015. Doctoral Dissertation, NEOMED Integrated Pharmaceutical Medicine. Accessed July 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1441828458.

MLA Handbook (7th Edition):

Wehrung, Daniel. “Development and Evaluation of Novel Light-Responsive Drug Delivery Systems from Alkoxyphenacyl Polycarbonates.” 2015. Web. 19 Jul 2019.

Vancouver:

Wehrung D. Development and Evaluation of Novel Light-Responsive Drug Delivery Systems from Alkoxyphenacyl Polycarbonates. [Internet] [Doctoral dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2015. [cited 2019 Jul 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1441828458.

Council of Science Editors:

Wehrung D. Development and Evaluation of Novel Light-Responsive Drug Delivery Systems from Alkoxyphenacyl Polycarbonates. [Doctoral Dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2015. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1441828458

6. Smith, Matthew Alan. Unveiling the Impact of the “-opathies”: Axonopathy, Dysferopathy, and Synaptopathy in Glaucomatous Neurodegeneration.

Degree: PhD, Integrated Pharmaceutical Medicine, 2017, NEOMED Integrated Pharmaceutical Medicine

 With a global prevalence of 3.54% for a population aged 40-80 years and projections indicating worldwide affliction numbers increasing to 76 million people by 2020,… (more)

Subjects/Keywords: Neurosciences; Aging; Biomedical Research; glaucoma; retinal ganglion cell; node of ranvier; superior colliculus; axons; g-ratio; electron microscopy; DBA; axonopathy; synaptopathy; immunofluorescence; caspr; sodium channels

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smith, M. A. (2017). Unveiling the Impact of the “-opathies”: Axonopathy, Dysferopathy, and Synaptopathy in Glaucomatous Neurodegeneration. (Doctoral Dissertation). NEOMED Integrated Pharmaceutical Medicine. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1523282895761979

Chicago Manual of Style (16th Edition):

Smith, Matthew Alan. “Unveiling the Impact of the “-opathies”: Axonopathy, Dysferopathy, and Synaptopathy in Glaucomatous Neurodegeneration.” 2017. Doctoral Dissertation, NEOMED Integrated Pharmaceutical Medicine. Accessed July 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1523282895761979.

MLA Handbook (7th Edition):

Smith, Matthew Alan. “Unveiling the Impact of the “-opathies”: Axonopathy, Dysferopathy, and Synaptopathy in Glaucomatous Neurodegeneration.” 2017. Web. 19 Jul 2019.

Vancouver:

Smith MA. Unveiling the Impact of the “-opathies”: Axonopathy, Dysferopathy, and Synaptopathy in Glaucomatous Neurodegeneration. [Internet] [Doctoral dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2017. [cited 2019 Jul 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1523282895761979.

Council of Science Editors:

Smith MA. Unveiling the Impact of the “-opathies”: Axonopathy, Dysferopathy, and Synaptopathy in Glaucomatous Neurodegeneration. [Doctoral Dissertation]. NEOMED Integrated Pharmaceutical Medicine; 2017. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ne2mh1523282895761979

.